A new interleukin to treat arthrites: anti-interleukin-6
Immunopathological aspects of interleukin-6 are analyzed, as well as the clinical use of tocilizumab, its safety and efficacy. Several studies have demonstrated that the blockade of interleukin-6 may bring a therapeutic benefit to rheumatoid arthritis patients. Tocilizumab is a humanized monoclonal...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2009-03-01
|
| Series: | Einstein (São Paulo) |
| Subjects: | |
| Online Access: | http://apps.einstein.br/revista/arquivos/PDF/1172-einsteinv7n1p108_11_eng.pdf |